Brad Kreger is a medical device and manufacturing executive who became CEO of Baltimore-based CoapTech in November 2025, taking over from co-founder Howard Carolan. He brings nearly three decades of operations experience, most recently turning around metal 3D-printing company Velo3D as its CEO, with earlier senior roles at Fluidigm/Standard BioTools, Thermo Fisher Scientific, and Affymetrix. At CoapTech he leads commercialization of the percutaneous ultrasound gastrostomy (PUG) system, an ultrasound-guided method of placing feeding tubes at the bedside that has been used in more than 1,000 patients.
Gajus Worthington is a life sciences entrepreneur, engineer, and inventor who turned an idea for circuits that move fluid instead of electrons into Fluidigm, a microfluidics company he co-founded in 1999 and led as CEO through its IPO and years as a public company. Today he is Chairman and CEO of Superfluid Dx, a South San Francisco company building a blood test that reads cell-free messenger RNA from the brain to diagnose Alzheimer's disease earlier and more precisely. Between those chapters he served as COO of the Chan Zuckerberg Biohub, co-founded Kaizen Therapeutics and the ML/AI healthcare company StatOS, and became a Managing Partner at WRQ Sciences.